Ajit Dash
Impact in
- Pharmacology top 2%
- Drug-Induced Hepatotoxicity and Protection
- Biomedical Engineering top 5%
- 3D Printing in Biomedical Research
- Microfluidic and Capillary Electrophoresis Applications
Papers in
-
- Drug-Induced Hepatotoxicity and Protection 9
-
- Asthma and respiratory diseases 4
- Co-authors
- Linda G. Griffith (3 shared papers)Karel Domanský (1 shared paper)James Serdy (1 shared paper)Matthew H. M. Lim (1 shared paper)Brian R. Wamhoff (8 shared papers)Ryan E. Feaver (4 shared papers)Robert A. Figler (5 shared papers)Banumathi K. Cole (3 shared papers)
- Journals
- Expert Opinion on Drug Metabolism & Toxicology (3 papers)Drug Safety (2 papers)Journal of Allergy and Clinical Immunology (2 papers)Chemico-Biological Interactions (1 paper)Molecular Genetics and Metabolism (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Ajit Dash
25 papers receiving 1.4k citations
Ajit Dash's Hit Papers
Peers
Comparison fields: 5 of 80
- Pharmacology 249
- Biomedical Engineering 528
- Hepatology 88
- Physiology 176
- Small Animals 54
Countries citing papers authored by Ajit Dash
This map shows the geographic impact of Ajit Dash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ajit Dash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ajit Dash more than expected).
Fields of papers citing papers by Ajit Dash
This network shows the impact of papers produced by Ajit Dash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ajit Dash. The network helps show where Ajit Dash may publish in the future.
Co-authors
The 25 scholars most cited alongside Ajit Dash, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 392 | |
| 2 | Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial Hit paper breakdown → | 2021 | 252 |
| 3 | 2009 | 142 | |
| 4 | 2016 | 127 | |
| 5 | 2013 | 97 | |
| 6 | 2007 | 72 | |
| 7 | 2017 | 67 | |
| 8 | 2022 | 56 | |
| 9 | 2016 | 50 | |
| 10 | 2019 | 35 | |
| 11 | 2020 | 32 | |
| 12 | 2015 | 31 | |
| 13 | 2016 | 31 | |
| 14 | 2022 | 29 | |
| 15 | 2023 | 20 | |
| 16 | 2010 | 16 | |
| 17 | 2012 | 16 | |
| 18 | 2015 | 16 | |
| 19 | 2024 | 6 | |
| 20 | 2024 | 5 |
About Ajit Dash
Ajit Dash is a scholar working on Pharmacology, Physiology, Epidemiology, Biomedical Engineering and Immunology, having authored 25 papers that have together received 1.5k indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (9 papers), Liver Disease Diagnosis and Treatment (4 papers), Asthma and respiratory diseases (4 papers), 3D Printing in Biomedical Research (4 papers), IL-33, ST2, and ILC Pathways (2 papers), Inflammatory Bowel Disease (2 papers), Dermatology and Skin Diseases (1 paper) and Metabolism and Genetic Disorders (1 paper). The work is most often cited by research in Pharmacology (249 citations), Biomedical Engineering (528 citations), Hepatology (88 citations), Physiology (176 citations) and Small Animals (54 citations). Ajit Dash has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Linda G. Griffith, Karel Domanský, James Serdy, Matthew H. M. Lim, Brian R. Wamhoff, Ryan E. Feaver, Robert A. Figler, Banumathi K. Cole, Steven R. Tannenbaum and Arun Jayant Sanyal. Their work appears in journals such as Expert Opinion on Drug Metabolism & Toxicology, Drug Safety, Journal of Allergy and Clinical Immunology, Chemico-Biological Interactions and Molecular Genetics and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.